These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 21135826)

  • 1. Straight talk with...Ellen 't Hoen.
    Mullard A
    Nat Med; 2010 Dec; 16(12):1351. PubMed ID: 21135826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
    Spectar JM
    Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of intellectual property rights in treatment access: challenges and solutions.
    't Hoen E; Passarelli CA
    Curr Opin HIV AIDS; 2013 Jan; 8(1):70-4. PubMed ID: 23201855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
    Muula AS
    Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
    Jain D; Darrow JJ
    Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
    Marques UR; Guimarães VS; Sternberg C
    Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
    [No Abstract]   [Full Text] [Related]  

  • 7. Intellectual property and access to ART: unwise choice of terminology.
    Stallman R
    PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062
    [No Abstract]   [Full Text] [Related]  

  • 8. Health GAP coalition--new group for international treatment access.
    AIDS Treat News; 1999 Mar; (No 315):5-6. PubMed ID: 11366560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Brazilian experiment: HIV drugs for all.
    Flaer PJ; Younis MZ
    J Health Care Finance; 2009; 36(2):90-6. PubMed ID: 20499725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
    Dionisio D; Gass R; McDermott P; Racalbuto V; Madeo M; Braghieri G; Crowley S; Pinheiro Edos S; Graaff P; Vasan A; Eksaengsri A; Moller H; Khanna AK; Kraisintu K; Juneja S; Nicolaou S; Sengupta A; Esperti F; Messeri D
    Curr HIV Res; 2007 Mar; 5(2):155-87. PubMed ID: 17346132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global patent police block cost-reduction efforts.
    Kasper T
    GMHC Treat Issues; 1999 Mar; 13(3):1-2. PubMed ID: 11366201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the Usefulness of Compulsory Licensing in Developing Countries: A Comparative Study of Thai and Brazilian Experiences Regarding Access to Aids Treatments.
    Guennif S
    Dev World Bioeth; 2017 Aug; 17(2):90-99. PubMed ID: 27699996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brazil's fight against AIDS and its implications for global health governance.
    Wogart JP; Calcagnotto G
    Healthc Q; 2006; 9(1):76-89. PubMed ID: 16548439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patents versus patients? Antiretroviral therapy in India.
    Havlir DV; Hammer SM
    N Engl J Med; 2005 Aug; 353(8):749-51. PubMed ID: 16120852
    [No Abstract]   [Full Text] [Related]  

  • 15. "Rights" and wrongs: what utility for the right to health in reforming trade rules on medicines?
    Forman L
    Health Hum Rights; 2008; 10(2):37-52. PubMed ID: 20845858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Africa, access, and patents: moving fast.
    James JS
    AIDS Treat News; 1999 Jul; (No 322):5-8. PubMed ID: 11366567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to generic antiretrovirals: inequality, intellectual property law, and international trade agreements.
    Castro A; Westerhaus M
    Cad Saude Publica; 2007; 23 Suppl 1():S85-96. PubMed ID: 17308722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Women and AIDS.
    Franks B
    N J Med; 2004 Nov; 101(11):76, 75. PubMed ID: 15605802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.